GlassScriptPhysician profile
Miranda Hohman
NPI 1538939418
$1,599.17
in general payments reported to CMS, 2019-2025
10 companies · $1,400 in 2025
The $1,400 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $199 · 2025: $1,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,599.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $623.45 | 2024-2025 | Biktarvy |
| Viiv Healthcare Company | $315.19 | 2025 | Cabenuva, Rukobia, Apretude |
| Insmed, INC. | $177.17 | 2024-2025 | Arikayce, Brinsupri |
| Shionogi INC | $171.22 | 2024-2025 | Fetroja |
| Merck Sharp & Dohme LLC | $82.19 | 2024-2025 | Zerbaxa, Delstrigo, Pifeltro |
| Paratek Pharmaceuticals, INC. | $77.42 | 2024-2025 | Nuzyra |
| Abbvie INC. | $70.68 | 2025 | |
| Melinta Therapeutics, LLC | $46.83 | 2025 | Rezzayo, Orbactiv, Kimyrsa |
| Dynavax Technologies Corporation | $21.38 | 2025 | Heplisav-B |
| Philips North America LLC | $13.64 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Hohman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.